KRAMPERA, Mauro
 Distribuzione geografica
Continente #
NA - Nord America 15.181
EU - Europa 11.159
AS - Asia 9.006
SA - Sud America 1.157
AF - Africa 137
OC - Oceania 40
Continente sconosciuto - Info sul continente non disponibili 20
AN - Antartide 1
Totale 36.701
Nazione #
US - Stati Uniti d'America 14.959
CN - Cina 3.369
GB - Regno Unito 3.352
SG - Singapore 3.298
IT - Italia 1.509
DE - Germania 1.065
BR - Brasile 1.009
FR - Francia 962
HK - Hong Kong 956
RU - Federazione Russa 953
SE - Svezia 948
IE - Irlanda 867
FI - Finlandia 786
KR - Corea 345
VN - Vietnam 285
UA - Ucraina 224
IN - India 137
JP - Giappone 128
CA - Canada 121
BE - Belgio 99
NL - Olanda 77
IR - Iran 75
ID - Indonesia 69
TR - Turchia 69
AT - Austria 61
MX - Messico 58
AR - Argentina 54
BD - Bangladesh 54
ES - Italia 50
PL - Polonia 37
AU - Australia 34
IQ - Iraq 34
ZA - Sudafrica 30
EC - Ecuador 25
UZ - Uzbekistan 24
TG - Togo 23
LT - Lituania 21
PK - Pakistan 21
MA - Marocco 20
RO - Romania 20
CL - Cile 19
EG - Egitto 19
MY - Malesia 19
CH - Svizzera 17
AZ - Azerbaigian 16
CZ - Repubblica Ceca 16
EU - Europa 16
CO - Colombia 14
IL - Israele 13
PT - Portogallo 12
VE - Venezuela 12
CM - Camerun 11
KE - Kenya 11
AE - Emirati Arabi Uniti 9
BG - Bulgaria 9
PH - Filippine 9
SA - Arabia Saudita 9
AL - Albania 8
GR - Grecia 8
KG - Kirghizistan 8
LV - Lettonia 8
PE - Perù 8
DK - Danimarca 7
KZ - Kazakistan 7
PY - Paraguay 7
NO - Norvegia 6
PA - Panama 6
AM - Armenia 5
CR - Costa Rica 5
HN - Honduras 5
HU - Ungheria 5
JM - Giamaica 5
LA - Repubblica Popolare Democratica del Laos 5
NI - Nicaragua 5
RS - Serbia 5
TH - Thailandia 5
TW - Taiwan 5
UY - Uruguay 5
BY - Bielorussia 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
LU - Lussemburgo 4
NZ - Nuova Zelanda 4
SK - Slovacchia (Repubblica Slovacca) 4
TN - Tunisia 4
BO - Bolivia 3
CG - Congo 3
CI - Costa d'Avorio 3
CY - Cipro 3
GT - Guatemala 3
LB - Libano 3
LK - Sri Lanka 3
MD - Moldavia 3
MK - Macedonia 3
MV - Maldive 3
NP - Nepal 3
PS - Palestinian Territory 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
Totale 36.658
Città #
Southend 2.971
Dallas 2.285
Jacksonville 1.958
Chandler 1.930
Singapore 1.613
Woodbridge 1.225
Hong Kong 945
Ashburn 898
Ann Arbor 885
Dublin 860
Houston 667
Beijing 461
Verona 339
Jinan 324
Lawrence 314
Princeton 314
Wilmington 305
Shenyang 299
New York 295
Nanjing 261
Munich 246
The Dalles 221
Los Angeles 209
Helsinki 155
Buffalo 149
Milan 141
Hebei 140
Tianjin 135
Sindelfingen 130
Zhengzhou 110
Columbus 107
Changsha 104
Turku 103
Nanchang 97
Brussels 93
São Paulo 92
Haikou 91
Redondo Beach 87
Seoul 86
Düsseldorf 85
Ningbo 85
Hangzhou 82
Santa Clara 81
Redmond 79
Boardman 75
Guangzhou 74
Ho Chi Minh City 71
Taizhou 71
Dong Ket 70
Taiyuan 70
Jiaxing 65
Novosibirsk 64
San Francisco 64
Seattle 63
Lancaster 59
Jakarta 55
Council Bluffs 54
Frankfurt am Main 53
Moscow 50
Bologna 46
Norwalk 46
Rome 46
Tokyo 46
Auburn Hills 38
Fairfield 38
Lanzhou 37
Toronto 36
Chicago 35
Kent 35
London 35
Vienna 34
Boston 33
Brooklyn 33
Rio de Janeiro 33
Dearborn 31
Fuzhou 31
Lappeenranta 31
Hanoi 30
Nuremberg 29
Redwood City 29
Stockholm 29
Falls Church 27
Warsaw 27
Montreal 26
Washington 26
Tehran 25
Madrid 24
Lomé 23
Mexico City 23
Tashkent 23
Brasília 21
Belo Horizonte 20
Chennai 20
Amsterdam 18
Phoenix 17
Atlanta 16
Johannesburg 16
Paris 16
Baku 15
Curitiba 15
Totale 24.194
Nome #
La citometria a flusso in Ematologia: aspetti tecnici e metodologici 441
Developmental pathways associated with cancer metastasis: Notch, Wnt, and Hedgehog 343
Valutazione immunofenotipica della malattia minima residua (MRD) nella leucemia acuta linfoblastica dell'adulto 299
Risk Factors for Persisting SARS-CoV-2 Infection in Patients with B-Cell Malignancies in the Omicron Era: A Multicenter Cohort Study 243
Interferon-alpha-engineered Multipotent Mesenchymal Stromal Cells for the treatment of myeloma 239
Meninges: from protective membrane to stem cell niche 230
Comparative Study of Immune Regulatory Properties of Stem Cells Derived from Different Tissues. 224
IFN-gamma- Mediated Upmodulation of MHC Class I Expression Activates Tumor-Specific Immune Response in a Mouse Model of Prostate Cancer 222
IFNalpha-producing bone marrow mesenchymal stem cells (BM-MSCs) contrast tumor growth in a mouse myeloma model. 210
In vitro characterization of the differentiation of meningeal Stem/precursor cells into the oligodendrocyte lineage 203
Comparison of epithelial differentiation and immune regulatory properties of mesenchymal stromal cells derived from human lung and bone marrow. 200
Acute lymphoblastic leukemia (ALL) in elderly patients receiving intensive treatment. Experience in 26 consecutive patients 197
Identification of microRNAs implicated in the late differentiation stages of normal B cells suggests a central role for miRNA targets ZEB1 and TP53 192
A new monoclonal antibody detects downregulation of protein tyrosine phosphatase receptor type γ in chronic myeloid leukemia patients 191
Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis. 190
Endothelin B Receptor (Etbr) expression by human malignant plasma cells: preliminary evidence for a role of the endothelin axis in multiple myeloma. 189
IN VITRO CHARACTERIZATION OF THE DIFFERENTIATION OF MENINGEAL STEM/PRECURSOR CELLS INTO THE OLIGODENDROCYTE LINEAGE 188
Analisi del riarrangiamento bcr-abl in alcuni pazienti affetti da leucemia mieloide cronica 186
HB-EGF/HER -1 SIGNALLING IN BONE MARROW MESENCHYMAL STEM CELLS: INDUCING CELL EXPANSION AND PREVENTING REVERSIBLY MULTI-LINEAGE DIFFERENTIATION 184
Migration of meningeal cells in response to contusive spinal cord injury 179
Meninges as a niche for stem/precursor cells with neural differentiation potential during development up to adulthood. 179
Notch singalling inhibition as a multi-target therapy to overcome bone marrow microenvironment-mediated drug resistance in AML 175
Molecular characterization of msc-derived extracellular vesicles and correlation with their immunomodulatory potential 175
In vitro characterization of the differentiation of meningeal stem/precursor cells into the oligodendrocyte lineage 173
Quantitative fluorescence in situ hybridization on paraffin embedded tissue. 172
Notch signalling drives bone marrow stromal cell-mediated chemoresistance in acute myeloid leukemia 171
Caratterizzazione immunofenotipica: principi ed applicazioni in Ematologia 169
Adult spinal cord meninges: A new source of neural stem cells 169
Role of GSK-3 signalling in non-promyelocitic acute myeloid leukemia (AML) cell response to chemotherapy 168
Adipose-derived stromal cells (ASCs) 168
Domanda di brevetto per modello di utilità nr. TO2010U000026 depositata il 23 Febbraio 2010 dal titolo: "DISPOSITIVO PER LA COLTURA CELLULARE", poi convertito in brevetto modello nazionale (nr. 272134) ed internazionale (PCT/IB2011/000365). 167
CAL2 Monoclonal Antibody Is a Rapid and Sensitive Assay for the Detection of Calreticulin Mutations in Essential Thrombocythemia and May Provide Prognostic Informations 167
Novel stem/progenitor cells with neuronal differentiation potential reside in the leptomeningeal niche 164
Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways 162
Adipocytes sustain pancreatic cancer progression through a non-canonical WNT paracrine network inducing ROR2 nuclear shuttling 162
Acute Myeloid Leukemia (AML) after BMT in a patient with Acute T-Lymphoblastic Leukemia (T-ALL) in CR, with no detectable minimal residual disease by flow-cytometry 159
BCR-ABL fusion transcript b2a2 is associated with a higher risk of non-optimal early response in CP-CML patients treated with standard dose imatinib: a study from Gruppo Triveneto LMC. 159
Role of stromal cell-mediated Notch signaling in CLL resistance to chemotherapy 158
CXCL12-MEDIATED NF-KAPPAB AND C-JUN ACTIVATION REGULATES INTERLEUKIN 8 PRODUCTION IN HUMAN T-LYMPHOBLASTIC LEUKEMIA 155
Inhibition of GSK-3 Signalling Enhances Sensitivity of Non-Promyelocitic Acute Myeloid Leukemia (AML) Cell to Chemotherapy 155
Induction of neural-like differentiation in human mesenchymal stem cells derived from bone marrow, fat, spleen and thymus 154
Differential and transferable modulatory effects of mesenchymal stromal cell-derived extracellular vesicles on T, B and NK cell functions 154
Homing and Efficacy Assessment of interferon-alpha-engineered mesenchymal stromal cells in a mouse plasmocytoma model 152
Efficacy assessment of interferon-alpha-engineered mesenchymal stromal cells in a mouse plasmacytoma model 152
A multiplex reverse transcriptase-polymerase chain reaction strategy for the diagnostic molecular screening of chimeric genes: a clinical evaluation on 170 patients with acute lymphoblastic leukemia. 151
Role of Wnt/β-Catenin Signalling in Acute Myeloid Leukemia (AML) Cell Response to Chemotherapy 151
Adipose derived mesenchimal stem cells and CNS: differentiation potential and immune suppression 148
Espressione del CD30 ligando sulle cellule di differenti neoplasie ematologiche leucemiche 146
IFN-gamma-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancer 145
HUMAN T-LYMPHOBLASTIC LEUKAEMIA CELLS PRODUCE IL-8 IN RESPONSE TOCXCL12 SECRETED BY NORMAL BONE MARROW STROMA 145
Inhibition of Notch signalling overcomes bone marrow stromal-mediated anti-apoptotic and chemoresistance effects in AML. 144
Effective control of acute myeloid leukaemia and acute lymphoblastic leukaemia progression by telomerase specific adoptive T-cell therapy 143
METHODOLOGICAL APPROACH TO MINIMAL RESIDUAL DISEASE DETECTION BY FLOW CYTOMETRY IN ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA 142
Mesenchymal stromal cells (MSCs) induce ex vivo proliferation and erythroid commitment of cord blood haematopoietic stem cells (CB-CD34+ cells) 142
Normal hematopoiesis and hematologic malignancies: role of canonical Wnt signaling pathway and stromal microenvironment 141
Meninges harbor cells expressing neural precursor markers during development and adulthood 141
Rational of targeting WNT/beta-catenin signaling in acute myeloid leukemia (AML) 141
Espressione e ruolo funzionale di CD30/CD30L e Fas/FasL in cellule endoteliali umane 140
Predictors of stable deep molecular response in chronic phase chronic myeloid leukemia patients treated with dasatinib or nilotinib after imatinib failure 140
IN VITRO STUDY OF THE MECHANISMS INVOLVED IN THE BONE MARROW MESENCHY- MAL STROMAL CELL MODULATORY EFFECT ON B CELL FUNCTIONS 139
The TNF-Family Cytokine TL1A Inhibits Proliferation of Human Activated B Cells 139
Expression and role of CD30/CD30L and Fas/FasL in human endothelial cells 138
CAL2 monoclonal antibody is a rapid and sensitive assay for the detection of calreticulin mutations in essential thrombocythemia and may provide prognostic informations 137
Clinical treatment of radiotherapy tissue damages by lipoaspirates transplant: a healing process mediated by adipose-derived adult stem cells (ASCs) 136
CHARACTERIZATION OF MESENCHYMAL STROMAL CELL-DERIVED EXTRACELLULAR VESICLES AND CORRELATION WITH THEIR IMMUNOSUPPRESSIVE PROPERTIES TOWARDS B CELLS 136
Importance of epigenetic changes in cancer etiology, pathogenesis, clinical profiling, and treatment: What can be learned from hematologic malignancies? 135
Mesenchymal stem versus stromal cells: International Society for Cell & Gene Therapy (ISCT®) Mesenchymal Stromal Cell committee position statement on nomenclature 134
Serum levels of p55 and p75 soluble TNF receptors in adult acute leukaemia at diagnosis: correlation with clinical and biological features and outcome 133
Immunophenotypic approach to the detection of minimal residual disease in acute leukemia 133
Mesenchymal stem cells share molecular signature with mesenchymal tumor cells and favor early tumor growth in syngeneic mice 133
Extracellular Vesicles Mediate Mesenchymal Stromal Cell-Dependent Regulation of B Cell PI3K-AKT Signaling Pathway and Actin Cytoskeleton 133
A murine model for the study of the inhibitory effect on antigen-specific naïve and memory T cells by bone marrow mesenchymal stem cells 132
Computer-based drug management in a bone marrow transplant unit: a suitable tool for multiple prescriptions even in critical conditions 132
Effects of a Ceramic Biomaterial on Immune Modulatory Properties and Differentiation Potential of Human Mesenchymal Stromal Cells of Different Origin. 131
Bone marrow-derived stromal cells inhibit spontaneous apoptosis and induce proliferation in blasts of T acute lymphoblastic leukaemia: the role of interleukin 7 130
Cellular antigens and soluble molecules and cytokine receptors in leukemia and lymphoma: biological role and clinical applications 130
Interferon-alpha-engineered Multipotent Mesenchymal Stromal Cells for the treatment of myeloma 130
Outcomes in first relapsed-refractory younger patients with mantle cell lymphoma: results from the MANTLE-FIRST study 130
Bone marrow mesenchymal stem cells express HER-1 and are sensitive to the effect of HB-EGF 129
Adult human and mouse spleen and thymus: alternative sources of mesenchymal stem cells with the same multilineage differentiation potential and immunoregulatory properties of those from bone marrow 128
The puzzling uniqueness of the heterotrimeric G15 protein and its potential beyond hematopoiesis 128
Adipose-derived mesenchymal stem cells maintains their stem profile with aging. 127
Bone marrow-, spleen- and thymus-derived mesenchymal stem cells favour the growth of myeloma cells in a mouse model 126
The rs1001179 SNP and CpG methylation regulate catalase expression in chronic lymphocytic leukemia 125
Sequential high dose chemotherapy with PBSC rescue in advanced hematologic malignancies 125
Multipotent stem cell with neural differentiation potential reside in the leptomeninges 125
Assetto citochinico e pattern del CD30 durante la maturazione del sistema immunitario 124
In Vitro and In Vivo Model of EBV-Positive Non-Hodgkin Plasmablastic Lymphoma with Focal Plasmacytic Differentiation 124
Guided differentiation of MSCs for regeneration of perimplant bone 124
Impact of allogenic and autologous bone marrow transplantation on acute non-lymphoblastic leukemia treatment: a retrospective study 121
Immune Modulation by Mesenchymal Stem Cells 121
Preventive and therapeutic beneficial effect of adipose-derived mesenchymal stem cells in chronic EAE 121
CAL2 monoclonal antibody is a rapid and sensitive assay for the detection of calreticulin mutations in essential thrombocythemia patients 121
Neural stem cell niches in health and diseases 121
Immunohistochemical and flow cytometric analysis of the expression of cyclin-dependent kinase 6 (CDK6, PLSTIRE) in cortical thymocytes and T-cell lymphoblastic lymphoma/leukemia 120
Cytogenetic response to intensive chemotherapy in chronic myelogenous leukemia patients 120
Homing and migration of transplanted leptomeningeal stem/progenitor cells in adult rat brain 120
Meninges as a niche for stem/precursor cells with neural differentiation potential during development up to adulthood 120
Mesenchymal Stromal Cells interplay with Umbilical Cord Blood Hematopoietic Progenitor Cells for hematopoietic reconstitution. Co-culturing effects and Gene Expression Profiles 120
Jagged-1, Jagged-2 and DLL-1 are the elements of Notch signaling mainly responsible for the antiapoptotic effect on B-lineage acute lymphoblastic leukemia exerted by bone marrow Mesenchymal Stem Cells 119
Totale 15.899
Categoria #
all - tutte 132.681
article - articoli 75.226
book - libri 0
conference - conferenze 54.709
curatela - curatele 0
other - altro 406
patent - brevetti 610
selected - selezionate 0
volume - volumi 1.730
Totale 265.362


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.120 0 0 0 387 339 351 47 218 203 32 358 185
2021/20222.615 304 707 38 175 120 54 31 154 102 92 234 604
2022/20235.503 405 565 509 1.047 455 1.336 30 327 569 47 133 80
2023/20243.038 110 211 257 303 339 502 191 175 33 207 475 235
2024/20257.624 440 493 360 1.202 364 277 311 300 1.210 476 712 1.479
2025/20265.403 1.538 1.741 1.872 252 0 0 0 0 0 0 0 0
Totale 37.113